Drug
Sagopilone (BAY86-5302, ZK 219477)
Sagopilone (BAY86-5302, ZK 219477) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
3
75%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
NCT00299390
completedphase_2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer
NCT00160069
completedphase_2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
NCT00288249
completedphase_1
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
NCT00359359
Clinical Trials (4)
Showing 4 of 4 trials
NCT00299390Phase 2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
NCT00160069Phase 2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer
NCT00288249Phase 2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
NCT00359359Phase 1
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4